Gynaecology Research - Pap Smears, Laparoscopy, Ultrasound, Hysteroscopy

Gynaecology Research Today is a free monthly online journal that collates and summarizes the latest research about Gynaecology, including details on pap smears, laparoscopy, ultrasound, hysteroscopy.


Gynaecology Research Today

Home

View Latest Issue

Information About Gynaecology

Books on Gynaecology

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2008), Issue 5 (May)

  1. Physician reentry: a concept whose time has come.
    Obstet Gynecol, 111(5): 1195-8. [Abstract] [Full-text]
  2. High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women.
    Obstet Gynecol, 111(5): 1143-7. [Abstract] [Full-text]
  3. Dengue infection in pregnancy: prevalence, vertical transmission, and pregnancy outcome.
    Obstet Gynecol, 111(5): 1111-7. [Abstract] [Full-text]
  4. Prevalence of hepatitis B virus infection among women at reproductive age at a German university hospital.
    J Clin Virol. [Abstract] [Full-text]
  5. Term extrauterine pregnancy in a Nigerian mother: a complication of uterine dehiscence.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  6. Familial aggregation of endometriosis in the Yale Series.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  7. Early detection of a twin tubal pregnancy by Doppler sonography allows fertility-conserving laparoscopic surgery.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  8. Benign ovarian dermoid cyst complicated with rectal fistula formation: an unusual case.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  9. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  10. Large angioleiomyoma, rich of mast cell and sex hormone receptor expression.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  11. Vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy--efficacy, safety and patient satisfaction: a randomized controlled trial.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  12. Human Papillomavirus DNA Detected in Breast Milk.
    Pediatr Infect Dis J. [Abstract] [Full-text]
  13. What makes a good clinical teacher in medicine? A review of the literature.
    Acad Med, 83(5): 452-66. [Abstract] [Full-text]
  14. Relationship of time since childbirth and other pregnancy factors to premenopausal breast cancer prognosis.
    Obstet Gynecol, 111(5): 1167-73. [Abstract] [Full-text]
  15. Vaginal descent and pelvic floor symptoms in postmenopausal women: a longitudinal study.
    Obstet Gynecol, 111(5): 1148-53. [Abstract] [Full-text]
  16. Individualized norms of optimal fetal growth: fetal growth potential.
    Obstet Gynecol, 111(5): 1065-76. [Abstract] [Full-text]
  17. The natural history of clinically unrecognized anal sphincter tears over 10 years after first vaginal delivery.
    Obstet Gynecol, 111(5): 1058-64. [Abstract] [Full-text]
  18. Decreasing the incidence of anal sphincter tears during delivery.
    Obstet Gynecol, 111(5): 1053-7. [Abstract] [Full-text]
  19. Female sexual function and pelvic floor disorders.
    Obstet Gynecol, 111(5): 1045-52. [Abstract] [Full-text]
  20. Sexual function 6 months after first delivery.
    Obstet Gynecol, 111(5): 1040-4. [Abstract] [Full-text]
  21. Sleep duration, melatonin and breast cancer among Chinese women in Singapore.
    Carcinogenesis. [Abstract] [Full-text]
  22. Practical guidance for the management of aromatase inhibitor-associated bone loss.
    Ann Oncol. [Abstract] [Full-text]
  23. Domestic violence during pregnancy: survey of patients and healthcare providers.
    J Womens Health (Larchmt), 17(4): 557-67. [Abstract] [Full-text]
  24. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
    Pharmacotherapy, 28(5): 576-83. [Abstract] [Full-text]
  25. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice.
    J Womens Health (Larchmt), 17(4): 569-78. [Abstract] [Full-text]
  26. Genomic analysis of epithelial ovarian cancer.
    Cell Res, 18(5): 538-48. [Abstract] [Full-text]
  27. Comparison of 18F-FDG PET and MRI in Assessment of Uterine Smooth Muscle Tumors.
    J Nucl Med, 49(5): 708-712. [Abstract] [Full-text]
  28. Severe complication after termination of a second trimester cervical pregnancy.
    Fertil Steril. [Abstract] [Full-text]
  29. Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes.
    Differentiation. [Abstract] [Full-text]
  30. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Menopause. [Abstract] [Full-text]
  31. The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical development.
    Clin Cancer Res, 14(9): 2701-9. [Abstract] [Full-text]
  32. MicroRNA Expression Profiles in Serous Ovarian Carcinoma.
    Clin Cancer Res, 14(9): 2690-5. [Abstract] [Full-text]
  33. Altered MicroRNA Expression in Cervical Carcinomas.
    Clin Cancer Res, 14(9): 2535-42. [Abstract] [Full-text]
  34. Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep.
    Endocrinology. [Abstract] [Full-text]
  35. The Role of Activin A and Akt/GSK Signaling in Ovarian Tumor Biology.
    Endocrinology. [Abstract] [Full-text]
  36. Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.
    Endocrinology. [Abstract] [Full-text]
  37. Examination of cyclic changes in bovine luteal echotexture using computer-assisted statistical pattern recognition techniques.
    Anim Reprod Sci, 106(3): 289-97. [Abstract] [Full-text]
  38. Seasonal variation in medical student experience in an obstetrics and gynecology clerkship.
    Am J Obstet Gynecol, 198(5): e25-7. [Abstract] [Full-text]
  39. Role of bedside transvaginal ultrasonography in the diagnosis of tubo-ovarian abscess in the emergency department.
    J Emerg Med, 34(4): 429-33. [Abstract] [Full-text]
  40. Inadequate screening in patients evaluated by nongynecologists for cervical cancer: a case control analysis.
    Am J Obstet Gynecol, 198(5): e48-50. [Abstract] [Full-text]
  41. A challenge for the 21st century: whither physician-scientists in obstetrics, gynecology, and the reproductive sciences?
    Am J Obstet Gynecol, 198(5): 489-95. [Abstract] [Full-text]
  42. Ethical dimensions of the non-aggressive fetal management.
    Semin Fetal Neonatal Med. [Abstract] [Full-text]
  43. The familial risk of breast cancer in women with endometriosis from Yale series.
    Surg Oncol. [Abstract] [Full-text]
  44. Factors associated with postoperative recovery after laparoscopic and abdominal hysterectomy.
    Eur J Obstet Gynecol Reprod Biol. [Abstract] [Full-text]
  45. Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  46. Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology?
    Am J Obstet Gynecol. [Abstract] [Full-text]
  47. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  48. Morphologic effects of epithelial ion channels on the mouse uterus: differences between raloxifene analog (LY117018) and estradiol treatments.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  49. Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  50. Surgeons' experience and interaction effect in randomized controlled trials regarding new surgical procedures.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  51. Safety and efficacy of vaginal hysterectomy in the large uterus with the LigaSure bipolar diathermy system.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  52. Cryopreservation of human ovarian tissue by solid-surface vitrification.
    Eur J Obstet Gynecol Reprod Biol. [Abstract] [Full-text]
  53. Suture erosion rates and long-term surgical outcomes in patients undergoing sacrospinous ligament suspension with braided polyester suture.
    Am J Obstet Gynecol, 198(5): 600.e1-4. [Abstract] [Full-text]
  54. The relationship between obstructive sleep apnea, nocturia, and daytime overactive bladder syndrome in women.
    Am J Obstet Gynecol, 198(5): 598.e1-5. [Abstract] [Full-text]
  55. Effects of the incontinence dish pessary on urethral support and urodynamic parameters.
    Am J Obstet Gynecol, 198(5): 592.e1-5. [Abstract] [Full-text]
  56. Urethral circular smooth muscle in young and old women.
    Am J Obstet Gynecol, 198(5): 587.e1-5. [Abstract] [Full-text]
  57. The influence of industry sponsorship on the acceptance of abstracts and their publication.
    Am J Obstet Gynecol, 198(5): 579.e1-4. [Abstract] [Full-text]
  58. Changes in physical activity after abdominal sacrocolpopexy for advanced pelvic organ prolapse.
    Am J Obstet Gynecol, 198(5): 570.e1-5. [Abstract] [Full-text]
  59. Development and testing of a new instrument to measure fluid intake, output, and urinary symptoms: the questionnaire-based voiding diary.
    Am J Obstet Gynecol, 198(5): 559.e1-7. [Abstract] [Full-text]
  60. Abdominal sacrocolpopexy: anatomic outcomes and complications with Pelvicol, autologous and synthetic graft materials.
    Am J Obstet Gynecol, 198(5): 557.e1-5. [Abstract] [Full-text]
  61. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects.
    Am J Obstet Gynecol, 198(5): 553.e1-6. [Abstract] [Full-text]
  62. Quantitative anal sphincter electromyography in primiparous women with anal incontinence.
    Am J Obstet Gynecol, 198(5): 550.e1-6. [Abstract] [Full-text]
  63. Distribution of pelvic organ support measures in a population-based sample of middle-aged, community-dwelling African American and white women in southeastern Michigan.
    Am J Obstet Gynecol, 198(5): 548.e1-6. [Abstract] [Full-text]
  64. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure.
    Am J Obstet Gynecol, 198(5): 509.e1-8. [Abstract] [Full-text]
  65. A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
    Am J Obstet Gynecol, 198(5): e54-6. [Abstract] [Full-text]
  66. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Fertil Steril. [Abstract] [Full-text]
  67. Prognostic value of a proliferation index including MIB1 and argyrophilic nucleolar organizer regions proteins in node-negative breast cancer.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  68. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  69. Maternal serum alpha-fetoprotein values in type 1 and type 2 diabetic patients.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  70. Methicillin-resistant Staphylococcus aureus infection in the obstetric setting.
    J Midwifery Womens Health, 53(3): 247-50. [Abstract] [Full-text]
  71. Understanding herpes simplex virus: transmission, diagnosis, and considerations in pregnancy management.
    J Midwifery Womens Health, 53(3): 202-8. [Abstract] [Full-text]
  72. Placenta accreta in the first trimester of pregnancy: Sonographic findings.
    J Clin Ultrasound. [Abstract] [Full-text]
  73. Prenatal ultrasonographic features of Joubert syndrome.
    J Clin Ultrasound. [Abstract] [Full-text]
  74. Three-dimensional sonography of the placental and uterine spiral vasculature: Influence of maternal age and parity.
    J Clin Ultrasound. [Abstract] [Full-text]
  75. Sequence of cardiovascular changes in IUGR in pregnancies with and without preeclampsia.
    Prenat Diagn, 28(5): 377-83. [Abstract] [Full-text]
  76. Flow cytometric quantification of bacteria in vaginal swab samples self-collected by adolescents attending a gynecology clinic.
    J Microbiol Methods, 73(3): 216-26. [Abstract] [Full-text]
  77. Inherited unbalanced structural chromosome abnormalities at prenatal chromosome analysis are rarely ascertained through recurrent miscarriage.
    Prenat Diagn, 28(5): 408-11. [Abstract] [Full-text]
  78. Anxiety levels in women undergoing prenatal maternal serum screening for Down syndrome: the effect of a fast reporting system by mobile phone short-message service.
    Prenat Diagn, 28(5): 417-21. [Abstract] [Full-text]
  79. Pelvic denervation procedures: a current reappraisal.
    Int J Gynaecol Obstet, 101(3): 304-8. [Abstract] [Full-text]
  80. Mid-gestation pregnancy termination in rabbits by the progesterone antagonist aglepristone.
    Theriogenology, 69(9): 1056-60. [Abstract] [Full-text]
  81. A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer.
    Gynecol Oncol, 109(2): 280-4. [Abstract] [Full-text]
  82. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Gynecol Oncol, 109(2): 220-5. [Abstract] [Full-text]
  83. Proteomic analysis of human cervico-vaginal fluid displays differential protein expression in association with labor onset at term.
    J Proteome Res, 7(5): 1916-21. [Abstract] [Full-text]
  84. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study.
    Br J Cancer, 98(9): 1582-5. [Abstract] [Full-text]
  85. Who should be tested for fragile X carriership? A review of 1 center's pedigrees.
    Am J Obstet Gynecol, 198(5): e51-3. [Abstract] [Full-text]
  86. How well are we training residents in female pelvic medicine and reconstructive surgery?
    Am J Obstet Gynecol, 198(5): 567.e1-4. [Abstract] [Full-text]
  87. Management of an obstetric health care provider with acute parvovirus B19 infection.
    Am J Obstet Gynecol, 198(5): e33-4. [Abstract] [Full-text]
  88. Restoration of continence by pessaries: magnetic resonance imaging assessment of mechanism of action.
    Am J Obstet Gynecol, 198(5): 563.e1-6. [Abstract] [Full-text]
  89. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence.
    Am J Obstet Gynecol, 198(5): 555.e1-5. [Abstract] [Full-text]
  90. Variation of the obturator foramen and pubic arch of the female bony pelvis.
    Am J Obstet Gynecol, 198(5): 546.e1-4. [Abstract] [Full-text]
  91. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    Cancer, 112(10): 2221-7. [Abstract] [Full-text]
  92. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Cancer, 112(10): 2202-10. [Abstract] [Full-text]
  93. A case of recurrent hyperreactio luteinalis.
    Am J Obstet Gynecol, 198(5): e9-10. [Abstract] [Full-text]
  94. Genetic testing and breach of patient confidentiality: law, ethics, and pragmatics.
    Am J Obstet Gynecol, 198(5): 498.e1-4. [Abstract] [Full-text]
  95. Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion.
    Gynecol Oncol, 109(2): 226-33. [Abstract] [Full-text]
  96. Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks.
    Int J Gynaecol Obstet, 101(3): 253-8. [Abstract] [Full-text]
  97. Severe liver disease in pregnancy.
    Int J Gynaecol Obstet, 101(3): 277-80. [Abstract] [Full-text]
  98. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
    Gynecol Oncol, 109(2): 215-9. [Abstract] [Full-text]
  99. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer.
    Gynecol Oncol, 109(2): 263-9. [Abstract] [Full-text]
  100. Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception?
    Am J Obstet Gynecol, 198(5): e46-7. [Abstract] [Full-text]
  101. Effects of bilateral levator ani nerve injury on pelvic support in the female squirrel monkey.
    Am J Obstet Gynecol, 198(5): 585.e1-8. [Abstract] [Full-text]
  102. Validation of decision-making outcomes for female pelvic floor disorders.
    Am J Obstet Gynecol, 198(5): 575.e1-6. [Abstract] [Full-text]
  103. Measuring progress in reducing maternal mortality.
    Best Pract Res Clin Obstet Gynaecol, 22(3): 425-45. [Abstract] [Full-text]
  104. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma.
    Gynecol Oncol, 109(2): 255-62. [Abstract] [Full-text]
  105. Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.
    Gynecol Oncol, 109(2): 199-202. [Abstract] [Full-text]
  106. Histologic response of porcine collagen-coated and uncoated polypropylene grafts in a rabbit vagina model.
    Am J Obstet Gynecol, 198(5): 582.e1-7. [Abstract] [Full-text]
  107. First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth.
    Am J Obstet Gynecol, 198(5): e43-5. [Abstract] [Full-text]
  108. Peripartum hysterectomy in Taiwan.
    Int J Gynaecol Obstet, 101(3): 269-72. [Abstract] [Full-text]
  109. Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes.
    Int J Gynaecol Obstet, 101(3): 264-8. [Abstract] [Full-text]
  110. Maternal deaths due to hypertensive disorders in pregnancy.
    Best Pract Res Clin Obstet Gynaecol, 22(3): 559-67. [Abstract] [Full-text]
  111. Early oral hydration after cesarean delivery performed under regional anesthesia.
    Int J Gynaecol Obstet, 101(3): 273-6. [Abstract] [Full-text]
  112. Anticipated and perceived pain from midtrimester amniocentesis.
    Int J Gynaecol Obstet, 101(3): 290-4. [Abstract] [Full-text]
  113. Risk factors for recurrent shoulder dystocia, Washington state, 1987-2004.
    Am J Obstet Gynecol, 198(5): e16-24. [Abstract] [Full-text]
  114. Androgen-regulated cervical ripening: a structural, biomechanical, and molecular analysis.
    Am J Obstet Gynecol, 198(5): 543.e1-9. [Abstract] [Full-text]
  115. Universal screening for substance abuse at the time of parturition.
    Am J Obstet Gynecol, 198(5): e30-2. [Abstract] [Full-text]
  116. Ultrasonographic evaluation of myometrial thickness in twin pregnancies.
    Am J Obstet Gynecol, 198(5): 530.e1-10. [Abstract] [Full-text]
  117. Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restriction.
    Am J Obstet Gynecol, 198(5): 519.e1-9. [Abstract] [Full-text]
  118. Increasing the noninvasive management of rhesus isoimmunization.
    Int J Gynaecol Obstet, 101(3): 281-4. [Abstract] [Full-text]
  119. Maternal mortality and unsafe abortion.
    Best Pract Res Clin Obstet Gynaecol, 22(3): 533-48. [Abstract] [Full-text]
  120. Changing patterns of maternal mortality (HIV/AIDS related) in poor countries.
    Best Pract Res Clin Obstet Gynaecol, 22(3): 489-99. [Abstract] [Full-text]
  121. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Transfusion, 48(5): 953-7. [Abstract] [Full-text]
  122. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire.
    Am J Obstet Gynecol, 198(5): e11-3. [Abstract] [Full-text]
  123. Postoperative oral contraceptive exposure and risk of endometrioma recurrence.
    Am J Obstet Gynecol, 198(5): 504.e1-5. [Abstract] [Full-text]
  124. Interobserver agreement in intrapartum estimation of fetal head station.
    Int J Gynaecol Obstet, 101(3): 285-9. [Abstract] [Full-text]
  125. Impact of prolonged referral interval on colposcopic outcomes in women with moderate or severe dysplasia.
    Int J Gynaecol Obstet, 101(3): 245-7. [Abstract] [Full-text]
  126. Is routine infectious and toxicologic screening in preterm labor effective in predicting preterm birth?
    Am J Obstet Gynecol, 198(5): e38-42. [Abstract] [Full-text]
  127. Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood.
    Transfusion, 48(5): 871-6. [Abstract] [Full-text]
  128. Patients' attitudes associated with cesarean delivery on maternal request in an urban population.
    Am J Obstet Gynecol, 198(5): e35-7. [Abstract] [Full-text]
  129. Prostaglandin E2-regulated cervical ripening: analysis of proteoglycan expression in the rat cervix.
    Am J Obstet Gynecol, 198(5): 536.e1-7. [Abstract] [Full-text]
  130. Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes.
    Am J Obstet Gynecol, 198(5): 528.e1-5. [Abstract] [Full-text]
  131. Maternal mortality in well-resourced countries: is there still a need for confidential enquiries?
    Best Pract Res Clin Obstet Gynaecol, 22(3): 501-15. [Abstract] [Full-text]
  132. Blunt suture needle use in laceration and episiotomy repair at vaginal delivery.
    Am J Obstet Gynecol, 198(5): e14-5. [Abstract] [Full-text]
  133. Antepartum uterine contraction patterns in twin pregnancies with and without preterm labor and delivering before or after 36 weeks.
    Am J Obstet Gynecol, 198(5): e28-9. [Abstract] [Full-text]
  134. Preeclampsia: impaired inflammatory response mediated by Toll-like receptors.
    J Reprod Immunol, 78(1): 80-3. [Abstract] [Full-text]
  135. Possible role of hematopoietic CD44/chondroitin sulfate interaction in extravasation of peripheral blood CD16(-) natural killer cells into human endometrium.
    J Reprod Immunol, 78(1): 1-10. [Abstract] [Full-text]
  136. Ex vivo cytokine production by whole mid-trimester amniotic fluid.
    J Reprod Immunol, 78(1): 22-7. [Abstract] [Full-text]
  137. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics.
    Am J Obstet Gynecol, 198(5): 496.e1-3. [Abstract] [Full-text]
  138. Implementing recommendations arising from confidential enquiries into maternal deaths.
    Best Pract Res Clin Obstet Gynaecol, 22(3): 477-87. [Abstract] [Full-text]
  139. Availability of gynecologic services in the department of veterans affairs.
    Womens Health Issues, 18(3): 167-73. [Abstract] [Full-text]
  140. An interviewer-administered validated female pelvic floor questionnaire for community-based research.
    Menopause. [Abstract] [Full-text]
  141. Spontaneous resolution of an adrenal mass seen on ultrasound at 17 weeks gestation.
    J Pediatr Hematol Oncol, 30(5): 405-6. [Abstract] [Full-text]
  142. Anesthesia for fetal surgery.
    Curr Opin Anaesthesiol, 21(3): 293-7. [Abstract] [Full-text]
  143. Epithelial Ovarian Tumors: Value of Dynamic Contrast-enhanced MR Imaging and Correlation with Tumor Angiogenesis.
    Radiology. [Abstract] [Full-text]
  144. Dysglycemia and a history of reproductive risk factors.
    Diabetes Care. [Abstract] [Full-text]
  145. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Clin Chim Acta, 392(1): 52-7. [Abstract] [Full-text]
  146. Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein.
    Clin Vaccine Immunol, 15(5): 817-24. [Abstract] [Full-text]
  147. Risk factors for perinatal deaths in Southern Japan: Population-based analysis from 1998 to 2005.
    Early Hum Dev, 84(5): 319-323. [Abstract] [Full-text]
  148. The Role of Intraoperative Frozen Section Histology in Obstetrical Brachial Plexus Reconstruction.
    J Reconstr Microsurg. [Abstract] [Full-text]
  149. Can pentoxifylline improve the sperm motion and ICSI success in the primary ciliary dyskinesia?
    Arch Gynecol Obstet. [Abstract] [Full-text]
  150. Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  151. Resolution of elevated postvoid residual volumes after correction of severe pelvic organ prolapse.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  152. Fertility drugs and risk of ovarian cancer: dispelling the myth.
    Curr Opin Obstet Gynecol, 20(3): 313-9. [Abstract] [Full-text]
  153. Does hyaluronan improve embryo implantation?
    Curr Opin Obstet Gynecol, 20(3): 305-7. [Abstract] [Full-text]
  154. The impact of disclosure on donor gamete participants: donors, intended parents and offspring.
    Curr Opin Obstet Gynecol, 20(3): 265-8. [Abstract] [Full-text]
  155. The role of mullerian inhibiting substance in female reproduction.
    Curr Opin Obstet Gynecol, 20(3): 257-64. [Abstract] [Full-text]
  156. Does glucocorticoid therapy in the peri-implantation period have an impact on IVF outcomes?
    Curr Opin Obstet Gynecol, 20(3): 249-56. [Abstract] [Full-text]
  157. Assessment of embryo viability in assisted reproductive technology: shortcomings of current approaches and the emerging role of metabolomics.
    Curr Opin Obstet Gynecol, 20(3): 234-41. [Abstract] [Full-text]
  158. Fragile X and reproduction.
    Curr Opin Obstet Gynecol, 20(3): 216-20. [Abstract] [Full-text]
  159. Reproductive assistance in HIV-1 discordant couples.
    Curr Opin Obstet Gynecol, 20(3): 205-10. [Abstract] [Full-text]
  160. Can preimplantation genetic diagnosis overcome recurrent pregnancy failure?
    Curr Opin Obstet Gynecol, 20(3): 199-204. [Abstract] [Full-text]
  161. Gender Specificity of Body Adiposity and Circulating Adiponectin, Visfatin, Insulin and IGF-I at Term Birth: Relation to Prenatal Growth.
    J Clin Endocrinol Metab. [Abstract] [Full-text]
  162. Hyperghrelinemia precedes obesity in Prader-Willi syndrome.
    J Clin Endocrinol Metab. [Abstract] [Full-text]
  163. Assisted reproductive technologies: how to minimize the risks and complications in developing countries?
    Hum Reprod. [Abstract] [Full-text]
  164. Affordable ART services in Africa: synthesis and adaptation of laboratory services.
    Hum Reprod. [Abstract] [Full-text]
  165. African experience with training courses on sperm examination.
    Hum Reprod. [Abstract] [Full-text]
  166. Type 3 deiodinase in hypoxia: to cool or to kill?
    Cell Metab, 7(5): 363-4. [Abstract] [Full-text]
  167. Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study.
    HIV Med. [Abstract] [Full-text]
  168. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    J Natl Cancer Inst, 100(9): 622-9. [Abstract] [Full-text]
  169. Bladder endometriosis: laparoscopic treatment and follow-up.
    Eur J Obstet Gynecol Reprod Biol. [Abstract] [Full-text]
  170. Infertility and psychiatric morbidity.
    Fertil Steril. [Abstract] [Full-text]
  171. Selective accumulation of PpIX and photodynamic effect after aminolevulinic acid treatment of human adenomyosis xenografts in nude mice.
    Fertil Steril. [Abstract] [Full-text]
  172. Small cell carcinoma of the ovary: clinical and biological study.
    Int J Clin Oncol, 13(2): 161-5. [Abstract] [Full-text]
  173. Transverse cystocele repair with uterine preservation using native tissue.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  174. Large vesicovaginal fistula in women with pelvic organ prolapse: the role of colpocleisis revisited.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  175. Decreased expression of endometrial vessel AQP1 and endometrial epithelium AQP2 related to anovulatory uterine bleeding in premenopausal women.
    Menopause. [Abstract] [Full-text]
  176. Effect of exercise on pregnancy outcome.
    Clin Obstet Gynecol, 51(2): 467-80. [Abstract] [Full-text]
  177. Psychosocial dimensions of HIV infection in pregnancy.
    Clin Obstet Gynecol, 51(2): 456-66. [Abstract] [Full-text]
  178. Smoking cessation in pregnancy: why, how, and what next...
    Clin Obstet Gynecol, 51(2): 419-35. [Abstract] [Full-text]
  179. Nutrition and pregnancy.
    Clin Obstet Gynecol, 51(2): 409-18. [Abstract] [Full-text]
  180. Trauma during pregnancy: outcomes and clinical management.
    Clin Obstet Gynecol, 51(2): 398-408. [Abstract] [Full-text]
  181. Intimate partner violence and its implication for pregnancy.
    Clin Obstet Gynecol, 51(2): 385-97. [Abstract] [Full-text]
  182. Psychosocial stress and pregnancy outcome.
    Clin Obstet Gynecol, 51(2): 333-48. [Abstract] [Full-text]
  183. Sexually transmitted infections in adolescent women.
    Clin Obstet Gynecol, 51(2): 306-18. [Abstract] [Full-text]
  184. Abortion care for adolescents.
    Clin Obstet Gynecol, 51(2): 281-9. [Abstract] [Full-text]
  185. Contraceptive care for adolescents.
    Clin Obstet Gynecol, 51(2): 268-80. [Abstract] [Full-text]
  186. Müllerian anomalies.
    Clin Obstet Gynecol, 51(2): 214-22. [Abstract] [Full-text]
  187. The physical examination in pediatric and adolescent patients.
    Clin Obstet Gynecol, 51(2): 205-13. [Abstract] [Full-text]
  188. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
    Fertil Steril. [Abstract] [Full-text]
  189. Association of sperm apoptosis and DNA ploidy with sperm chromatin quality in human spermatozoa.
    Fertil Steril. [Abstract] [Full-text]
  190. Successful treatment of ovarian pregnancy with laparoscopy-assisted local injection of etoposide.
    Fertil Steril. [Abstract] [Full-text]
  191. Return to fertility after cessation of a continuous oral contraceptive.
    Fertil Steril. [Abstract] [Full-text]
  192. Side population cells contributed to the genesis of human endometrium.
    Fertil Steril. [Abstract] [Full-text]
  193. The AZF proteins.
    Int J Androl. [Abstract] [Full-text]
  194. Chemotherapy for gynecological malignancies in organ transplantation patients: report of two cases.
    Int J Gynecol Cancer. [Abstract] [Full-text]
  195. Human chorionic villous macrophages as a fetal biological shield from maternal chorionic gonadotropin.
    Dev Growth Differ, 50(5): 299-306. [Abstract] [Full-text]
  196. Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens.
    Clin Microbiol Infect, 14(6): 619-21. [Abstract] [Full-text]
  197. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement.
    J Clin Endocrinol Metab, 93(5): 1874-83. [Abstract] [Full-text]
  198. Factors related to declining luteal function in women during the menopausal transition.
    J Clin Endocrinol Metab, 93(5): 1711-21. [Abstract] [Full-text]
  199. Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.
    J Clin Endocrinol Metab, 93(5): 1662-9. [Abstract] [Full-text]
  200. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.
    J Clin Endocrinol Metab, 93(5): 1915-23. [Abstract] [Full-text]
  201. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria.
    Toxicol Sci, 103(2): 362-70. [Abstract] [Full-text]
  202. Care of the adolescent with HIV.
    Clin Obstet Gynecol, 51(2): 319-28. [Abstract] [Full-text]
  203. The initial adolescent preventive care visit.
    Clin Obstet Gynecol, 51(2): 190-204. [Abstract] [Full-text]
  204. Guidelines for venous thromboembolism and clinical practice in Italy: a nationwide survey.
    Ann Vasc Surg, 22(3): 319-27. [Abstract] [Full-text]
  205. Do racial differences in knowledge about urogynecologic issues exist?
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  206. The prevalence of and potential risk factors for female urinary incontinence in Beijing, China.
    Menopause, 15(3): 566-9. [Abstract] [Full-text]
  207. Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells.
    Menopause, 15(3): 542-50. [Abstract] [Full-text]
  208. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.
    Menopause, 15(3): 524-9. [Abstract] [Full-text]
  209. Twisted Ovarian Tumor Causing Progressive Hemothorax: A Case Report of Porous Diaphragm Syndrome.
    Gynecol Obstet Invest, 66(2): 134-137. [Abstract] [Full-text]
  210. Efficient Production of Mice from Embryonic Stem Cells Injected Into 4- or 8- Cell Embryos by Piezo Micromanipulation.
    Stem Cells. [Abstract] [Full-text]
  211. Insulin and dexamethasone dynamically regulate adipocyte 11{beta}-hydroxysteroid dehydrogenase type 1.
    Endocrinology. [Abstract] [Full-text]
  212. Reproductive implications of endoscopic third ventriculostomy for the treatment of hydrocephalus.
    Eur J Obstet Gynecol Reprod Biol. [Abstract] [Full-text]
  213. Spontaneous unilateral dizygotic twin tubal pregnancy.
    J Clin Ultrasound. [Abstract] [Full-text]
  214. Interstitial pregnancy undetected during earlier first-trimester screening for fetal aneuploidy at 13 weeks' gestation.
    J Clin Ultrasound. [Abstract] [Full-text]
  215. Two cases of pregnant women with ovarian endometrioma mimicking a malignant ovarian tumor.
    J Clin Ultrasound. [Abstract] [Full-text]
  216. Incidental finding of an intrauterine device in the sigmoid colon.
    Eur J Contracept Reprod Health Care, 13(2): 212-4. [Abstract] [Full-text]
  217. Hysteroscopy in the evaluation of habitual abortions.
    Eur J Contracept Reprod Health Care, 13(2): 198-200. [Abstract] [Full-text]
  218. Are Serbian gynaecologists in line with modern family planning?
    Eur J Contracept Reprod Health Care, 13(2): 158-63. [Abstract] [Full-text]
  219. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives.
    Eur J Contracept Reprod Health Care, 13(2): 153-7. [Abstract] [Full-text]
  220. Training of residents in laparoscopic tubal sterilization: Long-term failure rates.
    Eur J Contracept Reprod Health Care, 13(2): 148-52. [Abstract] [Full-text]
  221. Herbal remedies for menopausal symptoms: Are we cautious enough?
    Eur J Contracept Reprod Health Care, 13(2): 133-7. [Abstract] [Full-text]
  222. Effects of aging on visuospatial performance and cerebral activation and lateralization: an FMRI study.
    Int J Neurosci, 118(6): 781-91. [Abstract] [Full-text]
  223. Preoperative Gender Differences in Pulmonary Gas Exchange in Morbidly Obese Subjects.
    Obes Surg. [Abstract] [Full-text]
  224. Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
    J Cancer Res Clin Oncol. [Abstract] [Full-text]
  225. Correlation between posterior vaginal wall defects assessed by clinical examination and by defecography.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  226. Pelvic organ prolapse symptoms in relation to POPQ, ordinal stages and ultrasound prolapse assessment.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  227. Knowledge to Action: Implementing a Guideline for Second Stage Labor.
    MCN Am J Matern Child Nurs, 33(3): 179-186. [Abstract] [Full-text]
  228. Childbirth Is Changing What Now?
    MCN Am J Matern Child Nurs, 33(3): 144-150. [Abstract] [Full-text]
  229. Metabolic assessment of the brain using proton magnetic resonance spectroscopy in a growth-restricted human fetus: case report.
    Am J Perinatol, 25(5): 305-9. [Abstract] [Full-text]
  230. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.
    BMJ, 336(7652): 1056-8. [Abstract] [Full-text]
  231. Ultrasonographic study of deep portion of diencephalo-telencephalic vesicle for the determination of gestational age of the canine foetus.
    Reprod Domest Anim, 43(3): 367-70. [Abstract] [Full-text]
  232. Locally elevated leukemia inhibitory factor in the inflamed fallopian tube resembles that found in tubal pregnancy.
    Fertil Steril. [Abstract] [Full-text]
  233. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
    Eur J Pain. [Abstract] [Full-text]
  234. Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma.
    Expert Rev Anticancer Ther, 8(5): 819-31. [Abstract] [Full-text]
  235. Interim analysis from the PATRICIA study group: efficacy of a vaccine against HPV 16 and 18.
    Expert Rev Anticancer Ther, 8(5): 701-5. [Abstract] [Full-text]
  236. Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats.
    J Bone Miner Metab, 26(3): 241-7. [Abstract] [Full-text]
  237. Stillbirth following previous cesarean section in Bavaria/Germany 1987-2005.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  238. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  239. Caesarean scar endometriosis.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  240. Restrictive dermopathy: a rare laminopathy.
    Arch Gynecol Obstet. [Abstract] [Full-text]
  241. Perineal ultrasound in the study of urethral mobility: proposal of a normal physiological range.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  242. Long-term effects of polychlorinated biphenyls and dioxins on pregnancy outcomes in women affected by the yusho incident.
    Environ Health Perspect, 116(5): 626-30. [Abstract] [Full-text]
  243. Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast.
    Mod Pathol. [Abstract] [Full-text]
  244. Infertility in African countries: challenges created by the HIV epidemic.
    Hum Reprod. [Abstract] [Full-text]
  245. Is there a limit for the number of in vitro fertilization cycles for an individual patient?
    Fertil Steril. [Abstract] [Full-text]
  246. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  247. New vs old: descriptors can affect patients' surgical preferences.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  248. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Am J Obstet Gynecol. [Abstract] [Full-text]
  249. Why laparoscopic adhesiolysis should not be the victim of a single randomized clinical trial.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  250. Oral and dental health care practices in pregnant women in Australia: a postnatal survey.
    BMC Pregnancy Childbirth, 8: 13. [Abstract] [Full-text]
  251. Surgical versus nonsurgical treatment of women with pelvic floor dysfunction: patient centered goals at 1 year.
    J Urol, 179(6): 2280-5; discussion 2285. [Abstract] [Full-text]
  252. Prolapse and incontinence surgery in older women.
    J Urol, 179(6): 2111-8. [Abstract] [Full-text]
  253. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure.
    J Urol, 179(6): 2286-90; discussion 2290. [Abstract] [Full-text]
  254. Multipotent properties of myofibroblast cells derived from human placenta.
    Cell Tissue Res, 332(3): 479-88. [Abstract] [Full-text]
  255. Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II.
    Peptides, 29(6): 1057-61. [Abstract] [Full-text]
  256. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
    Mol Carcinog, 47(6): 446-57. [Abstract] [Full-text]
  257. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer--the Addenbrooke's experience.
    Clin Oncol (R Coll Radiol), 20(5): 358-64. [Abstract] [Full-text]
  258. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
    Br J Cancer, 98(10): 1662-9. [Abstract] [Full-text]
  259. A case of silent rupture of an ectopic pregnancy.
    Spinal Cord. [Abstract] [Full-text]
  260. Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study.
    J Hypertens, 26(6): 1200-1208. [Abstract] [Full-text]
  261. Bacteria in the intestine, a helpful resident or an enemy from within?
    Infect Immun. [Abstract] [Full-text]
  262. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women.
    Menopause, 15(3): 536-541. [Abstract] [Full-text]
  263. Maternal nicotine exposure increases oxidative stress in the offspring.
    Free Radic Biol Med, 44(11): 1919-25. [Abstract] [Full-text]
  264. Molecular structure and function analysis of bikunin on down-regulation of tumor necrosis factor-alpha expression in activated neutrophils.
    Cytokine, 42(2): 191-7. [Abstract] [Full-text]
  265. Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression.
    Menopause, 15(3): 442-453. [Abstract] [Full-text]
  266. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women.
    Menopause, 15(3): 482-486. [Abstract] [Full-text]
  267. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
    Menopause, 15(3): 530-535. [Abstract] [Full-text]
  268. The importance of the (TAAAA)n alleles at the SHBG gene promoter for the severity of coronary artery disease in postmenopausal women.
    Menopause, 15(3): 461-468. [Abstract] [Full-text]
  269. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits.
    Menopause, 15(3): 503-510. [Abstract] [Full-text]
  270. Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women.
    Menopause, 15(3): 551-557. [Abstract] [Full-text]
  271. Perceptions of and attitudes toward estrogen therapy among surgically menopausal women in Taiwan.
    Menopause, 15(3): 517-523. [Abstract] [Full-text]
  272. The association between vascular function-related genes and age at natural menopause.
    Menopause, 15(3): 511-516. [Abstract] [Full-text]
  273. Diagnostic accuracy of endometrial thickness to exclude polyps in women with postmenopausal bleeding.
    J Clin Ultrasound, 36(5): 286-90. [Abstract] [Full-text]
  274. Fryns syndrome: case report and review of the literature.
    J Clin Ultrasound, 36(5): 315-7. [Abstract] [Full-text]
  275. Prenatal 3-dimensional sonographic and MRI findings in omphalocele-exstrophy-imperforate anus-spinal defects complex.
    J Clin Ultrasound, 36(5): 308-11. [Abstract] [Full-text]
  276. The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey.
    Int J Gynecol Cancer, 18(3): 439-45. [Abstract] [Full-text]
  277. Efficacy of a standardized technique of trans-vaginal entry into the peritoneal cavity for post-hysterectomy vaginal vault suspension.
    Int Urogynecol J Pelvic Floor Dysfunct. [Abstract] [Full-text]
  278. Gonadotropin-Releasing Hormone -I and II induce apoptosis in human granulosa cells.
    J Clin Endocrinol Metab. [Abstract] [Full-text]
  279. Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.
    Ann Oncol. [Abstract] [Full-text]
  280. Frequency and types of partner violence among Mexican American college women.
    J Am Coll Health, 56(6): 665-73. [Abstract] [Full-text]
  281. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe.
    Contraception, 77(6): 435-43. [Abstract] [Full-text]
  282. Comprehensive medical care for victims of sexual assault: a survey of Illinois hospital emergency departments.
    Contraception, 77(6): 426-30. [Abstract] [Full-text]
  283. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Contraception, 77(6): 420-5. [Abstract] [Full-text]
  284. Reproductive history, sexual behavior and use of contraception in women with epilepsy.
    Contraception, 77(6): 405-9. [Abstract] [Full-text]
  285. Evidence for association of sex hormone-binding globulin and androgen receptor genes with semen quality.
    Andrologia, 40(3): 186-91. [Abstract] [Full-text]
  286. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
    Int J Gynecol Cancer, 18(3): 499-505. [Abstract] [Full-text]
  287. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
    Proc Natl Acad Sci U S A, 105(19): 7004-9. [Abstract] [Full-text]
  288. Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
    Mol Cancer, 7: 35. [Abstract] [Full-text]
  289. Uro-genital bleeding in pre-menarcheal girls: dilemmas of child abuse.
    Pediatr Surg Int, 24(6): 745-6. [Abstract] [Full-text]
  290. The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
    Eur J Nucl Med Mol Imaging, 35(6): 1081-8. [Abstract] [Full-text]
  291. Pelvic ganglioneuroma.
    Int J Gynecol Cancer, 18(3): 553-6. [Abstract] [Full-text]
  292. A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix.
    Int J Gynecol Cancer, 18(3): 559-63. [Abstract] [Full-text]
  293. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.
    Int J Gynecol Cancer, 18(3): 487-91. [Abstract] [Full-text]
  294. Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer.
    Int J Gynecol Cancer, 18(3): 428-31. [Abstract] [Full-text]
  295. An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model.
    Int J Gynecol Cancer, 18(3): 432-8. [Abstract] [Full-text]
  296. Significance of E2F-1 overexpression in epithelial ovarian cancer.
    Int J Gynecol Cancer, 18(3): 492-8. [Abstract] [Full-text]
  297. Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report.
    Int J Gynecol Cancer, 18(3): 576-83. [Abstract] [Full-text]
  298. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
    Int J Gynecol Cancer, 18(3): 470-5. [Abstract] [Full-text]
  299. A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.
    Int J Gynecol Cancer, 18(3): 400-6. [Abstract] [Full-text]
  300. Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer.
    Int J Gynecol Cancer, 18(3): 515-24. [Abstract]